Skip to main content
Top
Published in: Acta Neurologica Belgica 4/2018

01-12-2018 | Original Article

Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study

Authors: Milica V. Jecmenica-Lukic, Tatjana D. Pekmezovic, Igor N. Petrovic, Natasa T. Dragasevic, Vladimir S. Kostić

Published in: Acta Neurologica Belgica | Issue 4/2018

Login to get access

Abstract

The aim of this study was to identify the main contributors to the health-related quality of life (HRQoL) in multiple system atrophy with predominant parkinsonism (MSA-P) and to determine the usefulness of SF-36 in capturing the HRQoL changes over 1-year follow-up. A total of 45 MSA-P and 150 Parkinson’s disease (PD) patients were studied. The hierarchical multiple regression analysis was conducted to identify predictors of the SF-36 total score. The magnitude of any change for the HRQoL over 1-year of follow-up, was calculated as an effect size. The average scores for each SF-36 domains, except for the bodily pain, were lower in MSA-P than in PD patients (p < 0.05). The most important predictors of HRQoL in MSA-P, were female gender, older age at onset, SCOPA-AUT score and UMSARS IV, which together with other selected clinical variables accounted for 84% of the variance in the total SF-36 score in the final model in hierarchical analyses. During the 1-year follow-up, the SF 36 was found capable of detecting changes in MSA-P. Our study provided some new insights into potential predictors of the HRQoL and its longitudinal changes in MSA-P, which should be considered when healthcare programs are developed.
Literature
1.
go back to reference Fanciulli A, Wenning G (2015) Multiple-system atrophy. N Engl J Med 372:249–263CrossRef Fanciulli A, Wenning G (2015) Multiple-system atrophy. N Engl J Med 372:249–263CrossRef
2.
go back to reference May S, Gilman S, Sowell BB et al (2007) Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 22(16):2371–2377CrossRef May S, Gilman S, Sowell BB et al (2007) Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 22(16):2371–2377CrossRef
3.
go back to reference Schrag A, Geser F, Stampfer-Kountchev M et al (2006) Health-related quality of life in multiple system atrophy. Mov Disord 21(6):809–815CrossRef Schrag A, Geser F, Stampfer-Kountchev M et al (2006) Health-related quality of life in multiple system atrophy. Mov Disord 21(6):809–815CrossRef
4.
go back to reference Calvert M, Pall H, Hoppitt T, Eaton B, Savill E, Sackley C (2013) Health-related quality of life and supportive care in patients with rare long-term neurological conditions. Qual Life Res 22(6):1573–2649CrossRef Calvert M, Pall H, Hoppitt T, Eaton B, Savill E, Sackley C (2013) Health-related quality of life and supportive care in patients with rare long-term neurological conditions. Qual Life Res 22(6):1573–2649CrossRef
5.
go back to reference Köllensperger M, Stampfer-Kountchev M, Seppi K et al (2007) Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment. Eur J Neurol 14(1):66–72CrossRef Köllensperger M, Stampfer-Kountchev M, Seppi K et al (2007) Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment. Eur J Neurol 14(1):66–72CrossRef
6.
go back to reference Gilman S, Low P, Quinn N, Albanese A et al (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 8(6):359–362CrossRef Gilman S, Low P, Quinn N, Albanese A et al (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 8(6):359–362CrossRef
7.
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRef
9.
go back to reference Hoehn M, Yahr M (1967) Parkinsonism: onset, progression, and mortality. Neurology 57(2):318–334CrossRef Hoehn M, Yahr M (1967) Parkinsonism: onset, progression, and mortality. Neurology 57(2):318–334CrossRef
10.
go back to reference Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease II. MacMillan, New York, pp 153–163 Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease II. MacMillan, New York, pp 153–163
11.
go back to reference Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19(12):1391–1402CrossRef Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19(12):1391–1402CrossRef
12.
go back to reference Hamilton MC (1960) Hamilton Depression Rating Scale (HAM-D). Redloc 23:56–62 Hamilton MC (1960) Hamilton Depression Rating Scale (HAM-D). Redloc 23:56–62
13.
go back to reference Hamilton M (1959) Hamilton Anxiety Rating Scale (HAM-A). J Med 61(4):81–82 Hamilton M (1959) Hamilton Anxiety Rating Scale (HAM-A). J Med 61(4):81–82
14.
go back to reference Starkstein SE, Mayberg SE, Preziosi TJ et al (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4(2):134–139CrossRef Starkstein SE, Mayberg SE, Preziosi TJ et al (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4(2):134–139CrossRef
15.
go back to reference Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRef Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRef
16.
go back to reference Mioshi E, Dawson K, Mitchell J et al (2006) The Addenbrooke’s cognitive examination revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21(11):1078–1085CrossRef Mioshi E, Dawson K, Mitchell J et al (2006) The Addenbrooke’s cognitive examination revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21(11):1078–1085CrossRef
17.
go back to reference Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626CrossRef Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626CrossRef
18.
go back to reference Visser M, Marinus J, Stiggelbout AM et al (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19(11):1306–1312CrossRef Visser M, Marinus J, Stiggelbout AM et al (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19(11):1306–1312CrossRef
19.
go back to reference Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 health survey manual and interpretation guide. New England Medical Center, Boston Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 health survey manual and interpretation guide. New England Medical Center, Boston
20.
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Academic Press, New York Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Academic Press, New York
21.
go back to reference Schrag A, Sheikh S, Quinn NP et al (2010) A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord 25(8):1077–1081CrossRef Schrag A, Sheikh S, Quinn NP et al (2010) A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord 25(8):1077–1081CrossRef
22.
go back to reference Winter Y, Spottke AE, Stamelou M et al (2011) Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 8(6):438–446CrossRef Winter Y, Spottke AE, Stamelou M et al (2011) Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 8(6):438–446CrossRef
23.
go back to reference Kass-Iliyya L, Kobylecki C, Mcdonald KR et al (2015) Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson’s disease. Brain Behav 5(5):2–5CrossRef Kass-Iliyya L, Kobylecki C, Mcdonald KR et al (2015) Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson’s disease. Brain Behav 5(5):2–5CrossRef
24.
go back to reference Colosimo C, Morgante L, Antonini A et al (2010) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257(1):5–14CrossRef Colosimo C, Morgante L, Antonini A et al (2010) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257(1):5–14CrossRef
25.
go back to reference Benrud-Larson LM, Sandroni P, Schrag A, Low PA (2005) Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 20(8):951–957CrossRef Benrud-Larson LM, Sandroni P, Schrag A, Low PA (2005) Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 20(8):951–957CrossRef
26.
go back to reference Pekmezovic T, Jecmenica-Lukic M, Petrovic I et al (2015) Quality of life in patients with progressive supranuclear palsy: one-year follow-up. J Neurol 262(9):2042–2048CrossRef Pekmezovic T, Jecmenica-Lukic M, Petrovic I et al (2015) Quality of life in patients with progressive supranuclear palsy: one-year follow-up. J Neurol 262(9):2042–2048CrossRef
27.
go back to reference Meissner WG, Foubert-Samier A, Dupouy S et al (2012) Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Mov Disord 27(12):1574–1577CrossRef Meissner WG, Foubert-Samier A, Dupouy S et al (2012) Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Mov Disord 27(12):1574–1577CrossRef
28.
go back to reference Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274CrossRef Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274CrossRef
Metadata
Title
Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study
Authors
Milica V. Jecmenica-Lukic
Tatjana D. Pekmezovic
Igor N. Petrovic
Natasa T. Dragasevic
Vladimir S. Kostić
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 4/2018
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-0962-4

Other articles of this Issue 4/2018

Acta Neurologica Belgica 4/2018 Go to the issue